SBA List Responds to SCOTUS Inaction on FDA Medical Safety Standards for Abortion Drugs

In response to news that the U.S. Supreme Court declined to act immediately on the Trump administration’s petition to uphold FDA medical safety standards for dangerous chemical abortion drugs, SBA List President Marjorie Dannenfelser issued the following comment:

“We are disappointed by the lack of a ruling. Chemical abortion poses serious complications for women that can include heavy bleeding, intense and prolonged pain, infection, and even death. Every day of delay is a day that unborn children and their mothers are at risk from these dangerous drugs. We thank the Trump administration for fighting for vitally important health and safety protections and are confident we will ultimately prevail.”

Share this article: